However, our observation that reducing insulin signaling can reduce, instead of aggravate, toxicity of Aβ suggests an alternative explanation: the association of insulin resistance or decrease of insulin signaling with AD may be considered a protective response to minimize the damage from Aβ. Here, INS is linked to Alzheimer disease.